DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Treatment Sequencing

Quickly grasp the optimal treatment sequence for your oncology brand with primary market research and physician insights.

  • What are physicians’ most frequent treatment sequences?
  • How are my drugs positioned in the treatment journey?
  • Which competitors are benefiting from popular treatment sequences?
  • How should I manage marketing messages for optimal growth?
  • How can I optimize trial design and ensure a competitive edge?



DRG’s Treatment Sequencing answers your key business questions to give your brand an edge.


Understand your drug's positioning across oncology indications. Coverage includes Breast Cancer, Non-small-cell lung cancer, Malignant melanoma, Colorectal cancer, Ovarian cancer, Bladder Cancer and Non-Hodgkin’s lymphoma/Chronic lymphocytic leukemia. Contact us to request your key therapy area.


Learn more